Former Congressman Waxman discusses the passage of the seminal Hatch-Waxman Act, recent proposals to improve the balance between rights of brand name pharmaceutical and generic companies, and his 40-year career in Congress.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.voiceofip.com